Human chorionic gonadotropin; LH-receptor agonist used in gonadal-axis research.
Also known as
Human chorionic gonadotropin · hCG · LH-receptor agonist
Overview
HCG is human chorionic gonadotropin, an LH-receptor agonist glycoprotein used in gonadal-axis and fertility research. Laboratory designs examine steroidogenesis, ovulation-related markers, and Leydig-cell signaling.
It is a glycoprotein hormone, not a short peptide, but appears beside GnRH/kisspeptin tools on research catalogs. Left Turn Adventures supplies this compound for laboratory and research use only.
Proven benefits
Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.
LH-receptor and steroidogenesis endpoints
• Gonadal-axis hormone markers (T, E2, P4 contexts)
• Ovulation and luteal research readouts where studied
• Leydig/theca cell signaling measures
• Comparative axis pharmacology versus GnRH analogs and kisspeptin
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: Early melanocortin or gonadal-axis signaling in acute models.
• Week 3–4: Clearer arousal, pigmentation, or hormone-axis markers in short research windows.
• Month 2–3: More stable pathway and behavioral endpoints in extended preclinical designs.
• Month 3–6: Sustained melanocortin or reproductive-axis observations where longer windows are used.
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.